GILD
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S · NEO:GILD
34.40 CAD−0.1400 −0.41%
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S (NEO:GILD) last traded at 34.40 CAD, down 0.41% on the day. Over the past year the stock is up 45.15%. Its 52-week range is 23.97 to 34.66. It is in the Health Technology sector (Biotechnology).
Key statistics
Open34.07
Day range34.07 – 34.40
52-week range23.97 – 34.66
Volume1.50 K
Average volume (10 days)1.64 K
Market cap (USD)211.64 B
EPS (TTM) (USD)−3.04
Dividend yield1.94%
Beta (1 year)0.5820
Revenue (TTM) (USD)30.29 B
Employees17.00 K
Performance
+7.27%1 week
+14.70%1 month
+30.85%3 months
+24.23%6 months
+37.38%Year to date
+45.15%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Gilead to Present Late-Breaking Clinical Data and Real-World Evidence at HIV GlasgowBusinessWire · 02 Nov 2026
- Why Did MO, GILD, XOM Stocks Surge To 52-Week Highs Last Week?Stocktwits · 02 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Gilead Sciences Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
- Gilead Sciences Is Maintained at Overweight by JP MorganDow Jones Newswires · 30 Oct 2026
- Gilead Sciences Price Target Raised to $188.00/Share From $165.00 by CitigroupDow Jones Newswires · 30 Oct 2026
- Gilead Sciences Is Maintained at Sector Outperform by ScotiabankDow Jones Newswires · 30 Oct 2026
- Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor ConferencesBusinessWire · 30 Oct 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.